These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36881070)

  • 1. Preferences Regarding Breast Surgery Omission Among Patients With Breast Cancer Who Receive Neoadjuvant Chemotherapy.
    Nakamura K; Ishitobi M; Oshiro C; Shima H; Takahashi E; Nakayama T; Shien T; Saito K; Iwatani T; Seto Y; Terata K; Kutomi G; Ogawa T; Inaji H
    In Vivo; 2023; 37(2):794-800. PubMed ID: 36881070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: risk factors of IBTR and validation of the MD Anderson Prognostic Index.
    Ishitobi M; Ohsumi S; Inaji H; Ohno S; Shigematsu H; Akiyama F; Iwase T; Akashi-Tanaka S; Sato N; Takahashi K; Oura S
    Cancer; 2012 Sep; 118(18):4385-93. PubMed ID: 22252882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Ipsilateral Breast Tumor Recurrence in Triple-Negative or HER2-Positive Breast Cancer Patients Who Achieve a Pathologic Complete Response After Neoadjuvant Chemotherapy.
    Ishitobi M; Matsuda N; Tazo M; Nakayama S; Tokui R; Ogawa T; Yoshida A; Kojima Y; Kuwayama T; Nakayama T; Yamauchi H; Nakamura S; Tsugawa K; Hayashi N
    Ann Surg Oncol; 2021 May; 28(5):2545-2552. PubMed ID: 33021710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical characteristics and prognosis of patients with ipsilateral breast tumor recurrence after breast conservation therapy].
    Sun GY; Wang SL; Tang Y; Jin J; Song YW; Liu YP; Wang WH; Fang H; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):352-358. PubMed ID: 29860762
    [No Abstract]   [Full Text] [Related]  

  • 5. Omission of Breast Surgery in Exceptional Responders.
    Tasoulis MK; Lee HB; Kuerer HM
    Clin Breast Cancer; 2024 Jun; 24(4):310-318. PubMed ID: 38365541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Multifocal Regression a Risk Factor for Ipsilateral Breast Tumor Recurrence in the Modern Era After Neoadjuvant Chemotherapy and Breast Conservation Therapy?
    Ling DC; Sutera PA; Iarrobino NA; Diego EJ; Soran A; Johnson RR; Bhargava R; Champ CE; Beriwal S
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):869-876. PubMed ID: 30885777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006).
    Gharzai LA; Szczygiel LA; Shumway DA; Bandos H; Julian TB; Mamounas EP; White J; De Los Santos JF; Basik M; Ganz PA; Jagsi R
    Breast Cancer Res Treat; 2021 Jun; 187(3):777-784. PubMed ID: 33740205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.
    Freedman G; Fowble B; Hanlon A; Nicolaou N; Fein D; Hoffman J; Sigurdson E; Boraas M; Goldstein L
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1005-15. PubMed ID: 10421533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast-conserving therapy after neoadjuvant chemotherapy: long-term results.
    Beriwal S; Schwartz GF; Komarnicky L; Garcia-Young JA
    Breast J; 2006; 12(2):159-64. PubMed ID: 16509842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Preference for Surgical Methods for Ipsilateral Breast Tumor Recurrence.
    Seto Y; Ishitobi M; Shien T; Oshiro C; Inoue H; Shima H; Kuba S; Watanabe N; Iwatani T; Nakayama T
    Ann Surg Oncol; 2024 Jul; 31(7):4512-4517. PubMed ID: 38594578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early response to neo-adjuvant chemotherapy in carcinoma of the breast predicts both successful breast-conserving surgery and decreased risk of ipsilateral breast tumor recurrence.
    Ishitobi M; Komoike Y; Motomura K; Koyama H; Inaji H
    Breast J; 2010; 16(1):9-13. PubMed ID: 19929889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
    Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery.
    Tadros AB; Yang WT; Krishnamurthy S; Rauch GM; Smith BD; Valero V; Black DM; Lucci A; Caudle AS; DeSnyder SM; Teshome M; Barcenas CH; Miggins M; Adrada BE; Moseley T; Hwang RF; Hunt KK; Kuerer HM
    JAMA Surg; 2017 Jul; 152(7):665-670. PubMed ID: 28423171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of factors related to periods to ipsilateral breast tumor recurrence after breast-conserving surgery and measures for preventing recurrence in early breast cancer.
    Nishimura R; Akizuki M; Tashima R; Ootao R
    Breast Cancer; 2006; 13(2):152-8. PubMed ID: 16755110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eliminating Breast Surgery for Invasive Cancer with Exceptional Response to Neoadjuvant Systemic Therapy: Prospective Multicenter Clinical Trial Planned Initial Feasibility Endpoint.
    Johnson HM; Valero V; Yang WT; Smith BD; Krishnamurthy S; Shen Y; Lin H; Lucci A; Rauch GM; Kuerer HM
    J Am Coll Surg; 2023 Jul; 237(1):101-108. PubMed ID: 36856291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locoregional recurrence of breast cancer in patients treated with breast conservation surgery and radiotherapy following neoadjuvant chemotherapy.
    Min SY; Lee SJ; Shin KH; Park IH; Jung SY; Lee KS; Ro J; Lee S; Kim SW; Kim TH; Kang HS; Cho KH
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e697-705. PubMed ID: 21129858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Tanaka-Akashi S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Breast Cancer; 2005; 12(2):104-11. PubMed ID: 15858440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment.
    Jwa E; Shin KH; Kim JY; Park YH; Jung SY; Lee ES; Park IH; Lee KS; Ro J; Kim YJ; Kim TH
    Cancer Res Treat; 2016 Oct; 48(4):1363-1372. PubMed ID: 26910473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe?
    Qu FL; Lin CJ; Liu ZB; Cao AY; Wu J; Liu GY; Yu KD; Di GH; Li JJ; Shao ZM
    Breast Cancer Res Treat; 2022 Nov; 196(1):97-109. PubMed ID: 36040640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.